SLDB earnings date and last-quarter result: next report 2026-08-11, last quarter beat, P/E -4.15. Updated 2026-07-23.
Solid Biosciences (SLDB) Research Hub
Solid Biosciences (SLDB) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 5.81 USD (-1.86%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.15, market cap 0.63B. This hub links to the full technical, earnings and options research available for SLDB.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 5.81 USD (-1.86%) |
| 52-week range | 5.385 USD – 11.45 USD |
| Trend regime | Range |
| 14-day RSI | 34.2 (Bearish) |
| Trailing P/E | -4.15 |
| Market cap | 0.63B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for SLDB
Covered Call on SLDB: how it works, illustrative setup around the real 5.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SLDB: how it works, illustrative setup around the real 5.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SLDB: how it works, illustrative setup around the real 5.81 USD price, max profit/loss, breakeven and when to use it. Educational.
SLDB technical analysis: range, last 5.81 USD, RSI 34.2, 52w range 5.385 USD–11.45 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SLDB in?
Solid Biosciences (SLDB) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SLDB in an uptrend or downtrend?
As of 2026-10-26, SLDB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SLDB's trailing P/E ratio?
SLDB's trailing P/E is -4.15, with a market cap of 0.63B. See the earnings research page for full valuation detail.
When does SLDB next report earnings?
SLDB is next scheduled to report earnings on 2026-08-11.